Rocky L. Baker - Concepedia

Concepedia

Author

Rocky L. Baker

University of Colorado Denver ORCID

Also Known As

R. Baker, ROCKY L. BAKER, Rocky Baker, Rocky L Baker, Rocky L. Baker, Rocky Lee Baker

54

Publications

1.6K

Citations

19

H-Index

54

Concepts

All Affiliations

University of Colorado Denver National Jewish Health University of Colorado Anschutz Medical Campus Benaroya Research Institute University of Montana

RL

About

Rocky L. Baker is an author at University of Colorado Denver specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	962
2	Allergy	3	3	170
3	Engineering	2	2	80
4	Natural Sciences	1	1	44
5	Biochemistry	1	1	44

Rocky L. Baker

×

22

Publications

1.6K

Citations

18

H-Index

	Year	Citations
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion Thomas Delong, Timothy A. Wiles, Rocky L. Baker, Science	2016	481
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts Kathryn J. Potter, Andisheh Abedini, Peter Marek, Proceedings of the National Academy of Sciences Porcine IappImmunologyTissue TransplantationPancreas TransplantationBiomedical Engineering	2010	169
Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A Thomas Delong, Rocky L. Baker, Jing He, Diabetes T-regulatory CellImmunologyImmune RegulationImmunologic MechanismAntigen Processing	2012	106
An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse Timothy A. Wiles, Thomas Delong, Rocky L. Baker, Journal of Autoimmunity Endogenous AntigenAutoimmune DiseaseInsulin ManagementDiabetesImmunology	2016	83
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes Rocky L. Baker, Marynette Rihanek, Anita C. Hohenstein, Diabetes Clinical ImmunologyGlycobiologyImmune RegulationImmunodominanceImmunology	2019	81
Chromogranin A is a T cell antigen in human type 1 diabetes Peter A. Gottlieb, Thomas Delong, Rocky L. Baker, Journal of Autoimmunity Autoimmune DiseaseDiabetesImmunologyPathologyChromogranin A	2013	74
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse Rocky L. Baker, Braxton L. Jamison, Timothy A. Wiles, Diabetes Adaptive Immune SystemT-regulatory CellImmunologyImmune RegulationImmunodominance	2018	65
Nanoparticles Containing an Insulin–ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells Braxton L. Jamison, Tobias Neef, Andrew Goodspeed, The Journal of Immunology EngineeringImmune RegulationImmunologyRegulatory T CellsAntigen Processing	2019	64
CD40 on NOD CD4 T cells contributes to their activation and pathogenicity Rocky L. Baker, David H. Wagner, Kathryn Haskins Journal of Autoimmunity Autoimmune DiseaseAdaptive Immune SystemT-regulatory CellPathogenesisImmunology	2008	59
Islet Amyloid Polypeptide Is a Target Antigen for Diabetogenic CD4+ T Cells Thomas Delong, Rocky L. Baker, Nichole Reisdorph, Diabetes	2011	59

Page 1